| Year |
Citation |
Score |
| 2020 |
Xian RR, Xie Y, Haley LM, Yonescu R, Pallavajjala A, Pittaluga S, Jaffe ES, Duffield AS, McCall CM, Gheith SMF, Gocke CD. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. Blood Cancer Journal. 10: 69. PMID 32555149 DOI: 10.1038/S41408-020-0335-0 |
0.317 |
|
| 2020 |
Spivak JL, Merchant A, Williams DM, Rogers O, Zhao W, Duffield A, Resar LS, Moliterno AR, Zhao ZJ. Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera. Plos One. 15: e0232801. PMID 32479500 DOI: 10.1371/Journal.Pone.0232801 |
0.332 |
|
| 2019 |
Van Slambrouck C, Huh J, Suh C, Song JY, Menon MP, Sohani AR, Duffield AS, Goldberg RC, Dama P, Kiyotani K, Godfrey J, Fitzpatrick C, Kline J, Smith SM, Jaffe ES, et al. Diagnostic utility of STAT6 expression in classical Hodgkin lymphoma and related entities. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31822802 DOI: 10.1038/S41379-019-0428-0 |
0.361 |
|
| 2019 |
Wu M, Li L, Hamaker M, Small D, Duffield AS. FLT3/ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways. Haematologica. PMID 30975911 DOI: 10.3324/Haematol.2018.208843 |
0.339 |
|
| 2019 |
Zhu R, Li L, Nguyen B, Duffield AS, Small D. Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIM Blood. 134: 2564-2564. DOI: 10.1182/Blood-2019-131635 |
0.365 |
|
| 2019 |
Wu M, Li L, Small D, Duffield AS. DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia Blood. 134: 2534-2534. DOI: 10.1182/Blood-2019-129157 |
0.308 |
|
| 2018 |
Annesley CE, Rabik C, Duffield AS, Rau RE, Magoon D, Li L, Huff V, Small D, Loeb DM, Brown P. Knock-in of the R394W mutation causes MDS and cooperates with to drive aggressive myeloid neoplasms in mice. Oncotarget. 9: 35313-35326. PMID 30450160 DOI: 10.18632/Oncotarget.26238 |
0.34 |
|
| 2018 |
Nagai K, Hou L, Li L, Nguyen B, Seale T, Shirley C, Ma H, Levis M, Ghiaur G, Duffield A, Small D. Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3. Oncotarget. 9: 32885-32899. PMID 30250637 DOI: 10.18632/Oncotarget.25972 |
0.383 |
|
| 2018 |
Gong S, Crane GM, McCall CM, Xiao W, Ganapathi KA, Cuka N, Davies-Hill T, Xi L, Raffeld M, Pittaluga S, Duffield AS, Jaffe ES. Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings. The American Journal of Surgical Pathology. PMID 29957733 DOI: 10.1097/Pas.0000000000001113 |
0.318 |
|
| 2018 |
Duffield AS, Ascierto ML, Anders RA, Taube JM, McMiller TL, Engle EL, Meeker AK, Berger AE, Pardoll DM, Ambinder RF, Topalian SL. Abstract 4750: The immunosuppressive tumor microenvironment (TME) in nasopharyngeal carcinoma: implications for immunotherapy Cancer Research. 78: 4750-4750. DOI: 10.1158/1538-7445.Am2018-4750 |
0.32 |
|
| 2016 |
Wu M, Hamaker M, Li L, Small D, Duffield AS. DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells. Leukemia. PMID 27748370 DOI: 10.1038/Leu.2016.284 |
0.417 |
|
| 2016 |
Crane GM, Samols MA, Morsberger LA, Yonescu R, Thiess ML, Batista DA, Ning Y, Burns KH, Vuica-Ross M, Borowitz MJ, Gocke CD, Ambinder RF, Duffield AS. Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived. Plos One. 11: e0163559. PMID 27685855 DOI: 10.1371/Journal.Pone.0163559 |
0.302 |
|
| 2016 |
Poitras JL, Heiser D, Li L, Nguyen B, Nagai K, Duffield AS, Gamper C, Small D. Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model. Oncotarget. PMID 27636998 DOI: 10.18632/Oncotarget.11986 |
0.334 |
|
| 2016 |
Alikhan M, Song JY, Sohani AR, Moroch J, Plonquet A, Duffield AS, Borowitz MJ, Jiang L, Bueso-Ramos C, Inamdar K, Menon MP, Gurbuxani S, Chan E, Smith SM, Nicolae A, et al. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27312067 DOI: 10.1038/Modpathol.2016.113 |
0.338 |
|
| 2016 |
Ma HS, Greenblatt SM, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Jung E, Aplan PD, Ghiaur G, Jones RJ, Small D. All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo. Blood. PMID 27103744 DOI: 10.1182/Blood-2015-05-646786 |
0.368 |
|
| 2016 |
Crane GM, Duffield AS. Hematolymphoid lesions of the sinonasal tract. Seminars in Diagnostic Pathology. 33: 71-80. PMID 26472692 DOI: 10.1053/J.Semdp.2015.09.008 |
0.311 |
|
| 2016 |
Nagai K, Hou L, Li L, Nguyen B, Shirley CM, Ma HS, Levis MJ, Duffield AS, Small D. Arsenic Trioxide Synergizes with FLT3 Tyrosine Kinase Inhibitors to Kill FLT3-ITD+ Leukemic Cells through Depressed Production and Degradation of FLT3 Protein Blood. 128: 1568-1568. DOI: 10.1182/Blood.V128.22.1568.1568 |
0.402 |
|
| 2015 |
Song JY, Venkataraman G, Fedoriw Y, Herrera AF, Siddiqi T, Alikhan MB, Kim YS, Murata-Collins J, Weisenburger DD, Liu X, Duffield AS. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leukemia & Lymphoma. 1-6. PMID 26450341 DOI: 10.3109/10428194.2015.1085529 |
0.32 |
|
| 2015 |
Kern JB, Hii A, Kruse MJ, Szabo Z, Argani P, Hibbard MK, Gladstone DE, Meyer C, Zheng R, Borowitz MJ, Duffield AS. A leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor. International Journal of Surgical Pathology. 23: 75-7. PMID 25305220 DOI: 10.1177/1066896914553666 |
0.323 |
|
| 2015 |
Ma HS, McCray ME, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Greenblatt S, Jung E, Aplan PD, Jones RJ, Small D, Ghiaur G. FLT3 Inhibition and Retinoid Signaling Overcome Stromal Protection to Target FLT3/ITD-Expressing Leukemia Stem Cells in the Bone Marrow Microenvironment Blood. 126: 790-790. DOI: 10.1182/Blood.V126.23.790.790 |
0.365 |
|
| 2015 |
Spivak JL, Williams DM, Zhao ZJ, Rogers O, Duffield AS, Hankins WD, Moliterno AR. MPL SV, a Unique MPN MPL Splice Variant, Provokes a Fulminant Myeloid Leukemia in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera Blood. 126: 484-484. DOI: 10.1182/Blood.V126.23.484.484 |
0.338 |
|
| 2015 |
Wu M, Li L, Hamaker M, Small D, Duffield AS. DOCK2 Regulates DNA Damage Response and Modulates the Sensitivity to Chemotherapeutic Agents in FLT3/ITD Leukemic Cells Blood. 126: 3668-3668. DOI: 10.1182/Blood.V126.23.3668.3668 |
0.364 |
|
| 2015 |
Annesley CE, Duffield AS, Rau RE, McCarty G, Magoon D, Li L, Huff V, Small D, Loeb D, Brown P. A Wilms Tumor 1 (WT1) Mutation Causes Myelodysplastic Syndrome in a Knock-in Mouse Model, and a Mixed Myelodysplastic/Myeloproliferative Neoplam in Double Knock-in Mice with WT1 and FLT3/ITD Mutations Blood. 126: 312-312. DOI: 10.1182/Blood.V126.23.312.312 |
0.341 |
|
| 2015 |
Crane GM, Powell H, Kostadinov R, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS. Lymphoproliferative Disease Risk in Patients with Autoimmune Disease: Clustering of Primary CNS Lymphoma with Drug Regimen and Disease Process Blood. 126: 1490-1490. DOI: 10.1182/Blood.V126.23.1490.1490 |
0.319 |
|
| 2014 |
Crane GM, Xian RR, Burns KH, Borowitz MJ, Duffield AS, Taube JM. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma. Journal of Cutaneous Pathology. 41: 928-35. PMID 25355615 DOI: 10.1111/Cup.12405 |
0.34 |
|
| 2014 |
Ma HS, Nguyen B, Duffield AS, Li L, Galanis A, Williams AB, Brown PA, Levis MJ, Leahy DJ, Small D. FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia. Cancer Research. 74: 5206-17. PMID 25060518 DOI: 10.1158/0008-5472.Can-14-1028 |
0.322 |
|
| 2014 |
Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. The American Journal of Surgical Pathology. 38: 426-32. PMID 24525514 DOI: 10.1097/Pas.0000000000000128 |
0.36 |
|
| 2014 |
Ma H, Nguyen B, Li L, Greenblatt S, Williams A, Zhao M, Levis M, Rudek M, Duffield A, Small D. TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo. Blood. 123: 1525-34. PMID 24408321 DOI: 10.1182/Blood-2013-08-523035 |
0.364 |
|
| 2014 |
Rau R, Magoon D, Greenblatt S, Li L, Annesley C, Duffield AS, Huso D, McIntyre E, Clohessy JG, Reschke M, Pandolfi PP, Small D, Brown P. NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease. Experimental Hematology. 42: 101-13.e5. PMID 24184354 DOI: 10.1016/J.Exphem.2013.10.005 |
0.33 |
|
| 2014 |
Xian RR, Swinnen LJ, Lin M, Gocke CD, Duffield A. Presentation of late-relapse diffuse large B-cell lymphomas in extranodal sites may represent recurrences of the original disease. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E19558 |
0.322 |
|
| 2014 |
Song JY, Venkataraman G, Fedoriw YD, Alikhan M, Kim Y, Weisenburger DD, Collins J, Liu X, Duffield AS. Burkitt Leukemia Involving Only the Bone Marrow Has a Better Prognosis Than Widespread Burkitt Lymphoma Involving the Bone Marrow in Adults Blood. 124: 4446-4446. DOI: 10.1182/Blood.V124.21.4446.4446 |
0.328 |
|
| 2014 |
Wu M, Hamaker M, Li L, Small D, Duffield AS. DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells Blood. 124: 3584-3584. DOI: 10.1182/Blood.V124.21.3584.3584 |
0.412 |
|
| 2014 |
Crane GM, Powell H, Kostadinov R, Ambinder RF, Swinnen LJ, Borowitz M, Duffield AS. A Rise in CNS Lymphoproliferative Disease Incidence Reveals a Protective Role of Calcineurin Inhibitors Blood. 124: 3020-3020. DOI: 10.1182/Blood.V124.21.3020.3020 |
0.307 |
|
| 2014 |
Xian RR, Crane GM, Haley LM, Gocke CD, Lin M, Pallavajjalla A, Borowitz MJ, Swinnen LJ, Duffield AS. Late-Relapse Diffuse Large B-Cell Lymphoma Frequently Represents Recurrence of the Original Disease, and Demonstrates Evidence of Superimposed Clonal Heterogeneity and Clonal Evolution Blood. 124: 2955-2955. DOI: 10.1182/Blood.V124.21.2955.2955 |
0.317 |
|
| 2013 |
Bailey E, Li L, Duffield AS, Ma HS, Huso DL, Small D. FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice. Proceedings of the National Academy of Sciences of the United States of America. 110: 21113-8. PMID 24255108 DOI: 10.1073/Pnas.1310559110 |
0.309 |
|
| 2013 |
Greenblatt SM, Jung E, Duffield AS, Li L, Ghiaur G, Jones RJ, Small D. All-Trans Retinoic Acid Synergizes With FLT3 Tyrosine Kinase Inhibition To Eliminate FLT3/ITD-Expressing Leukemia Cells Blood. 122: 3960-3960. DOI: 10.1182/Blood.V122.21.3960.3960 |
0.389 |
|
| 2012 |
McCall CM, Mudali S, Arceci RJ, Small D, Fuller S, Gocke CD, Vuica-Ross M, Burns KH, Borowitz MJ, Duffield AS. Flow cytometric findings in hemophagocytic lymphohistiocytosis. American Journal of Clinical Pathology. 137: 786-94. PMID 22523218 DOI: 10.1309/Ajcpp40Mexwyrlpn |
0.312 |
|
| 2012 |
Duffield AS, Aoki J, Levis M, Cowan K, Gocke CD, Burns KH, Borowitz MJ, Vuica-Ross M. Clinical and pathologic features of secondary acute promyelocytic leukemia. American Journal of Clinical Pathology. 137: 395-402. PMID 22338051 DOI: 10.1309/Ajcpe0Mv0Ytwluue |
0.324 |
|
| 2012 |
Greenblatt S, Li L, Slape C, Nguyen B, Novak R, Duffield A, Huso D, Desiderio S, Borowitz MJ, Aplan P, Small D. Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model. Blood. 119: 2883-94. PMID 22323452 DOI: 10.1182/Blood-2011-10-382283 |
0.344 |
|
| 2012 |
Emadi A, Sadrzadeh H, Patal P, Burns KH, Duffield A, Ballen KK, Amrein PC, Attar EC, Smith BD, Fathi AT. History of autoimmunity to predict clinical response to DNA methyltransferase inhibitors (DNMTI) in myelodysplastic syndromes (MDS), and MDS-derived acute myeloid leukemias (AML). Journal of Clinical Oncology. 30: 6629-6629. DOI: 10.1200/Jco.2012.30.15_Suppl.6629 |
0.33 |
|
| 2011 |
Stoll LM, Duffield AS, Johnson MW, Ali SZ. Acute myeloid leukemia with myelodysplasia-related changes with erythroid differentiation involving pleural fluid: a case report and brief cytopathologic review. Diagnostic Cytopathology. 39: 451-4. PMID 20954271 DOI: 10.1002/Dc.21470 |
0.338 |
|
| 2011 |
Greenblatt SM, Li L, Slape C, Novak RL, Duffield AS, Nguyen B, Huso D, Borowitz MJ, Aplan P, Small D. Knock-in of a FLT3 Internal Tandem Duplication Mutation Cooperates with a NUP98-HOXD13 Fusion to Generate Acute Myeloid Leukemia Blood. 118: 865-865. DOI: 10.1182/Blood.V118.21.865.865 |
0.361 |
|
| 2008 |
Duffield A, Caplan MJ, Muth TR. Protein trafficking in polarized cells. International Review of Cell and Molecular Biology. 270: 145-79. PMID 19081536 DOI: 10.1016/S1937-6448(08)01404-4 |
0.682 |
|
| 2008 |
Lin D, Kamsteeg EJ, Zhang Y, Jin Y, Sterling H, Yue P, Roos M, Duffield A, Spencer J, Caplan M, Wang WH. Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels. The Journal of Biological Chemistry. 283: 7674-81. PMID 18211905 DOI: 10.1074/Jbc.M705574200 |
0.52 |
|
| 2007 |
Kamsteeg EJ, Duffield AS, Konings IB, Spencer J, Pagel P, Deen PM, Caplan MJ. MAL decreases the internalization of the aquaporin-2 water channel. Proceedings of the National Academy of Sciences of the United States of America. 104: 16696-701. PMID 17940053 DOI: 10.1073/Pnas.0708023104 |
0.554 |
|
| 2007 |
Caplan MJ, Kamsteeg EJ, Duffield A. Tetraspan proteins: regulators of renal structure and function. Current Opinion in Nephrology and Hypertension. 16: 353-8. PMID 17565278 DOI: 10.1097/Mnh.0B013E328177B1Fa |
0.533 |
|
| 2004 |
Duffield A, Fölsch H, Mellman I, Caplan MJ. Sorting of H,K-ATPase beta-subunit in MDCK and LLC-PK cells is independent of mu 1B adaptin expression. Traffic (Copenhagen, Denmark). 5: 449-61. PMID 15117319 DOI: 10.1111/J.1398-9219.2004.00192.X |
0.525 |
|
| 2003 |
Duffield A, Kamsteeg EJ, Brown AN, Pagel P, Caplan MJ. The tetraspanin CD63 enhances the internalization of the H,K-ATPase beta-subunit. Proceedings of the National Academy of Sciences of the United States of America. 100: 15560-5. PMID 14660791 DOI: 10.1073/Pnas.2536699100 |
0.518 |
|
| 2003 |
Pagel P, Zatti A, Kimura T, Duffield A, Chauvet V, Rajendran V, Caplan MJ. Ion pump-interacting proteins: promising new partners. Annals of the New York Academy of Sciences. 986: 360-8. PMID 12763851 DOI: 10.1111/J.1749-6632.2003.Tb07215.X |
0.506 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Kwon R, Duffield AS. HTLV-1-associated adult T-cell leukemia/lymphoma with disseminated strongyloidiasis. Blood. 133: 2623. PMID 31196878 DOI: 10.1182/Blood.2019000290 |
0.298 |
|
| 2020 |
Schratz KE, Haley L, Danoff SK, Blackford A, DeZern A, Gocke CD, Duffield AS, Armanios M. Cancer spectrum and outcomes in the Mendelian short telomere syndromes. Blood. PMID 32076714 DOI: 10.1182/Blood.2019003264 |
0.296 |
|
| 2015 |
Crane GM, Powell H, Kostadinov R, Rocafort PT, Rifkin DE, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget. 6: 33849-66. PMID 26460822 DOI: 10.18632/Oncotarget.5292 |
0.295 |
|
| 2020 |
Thummalapalli R, Heumann T, Stein J, Khan S, Priemer DS, Duffield AS, Laterra J, Couzi R, Lim M, Holdhoff M. Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma. Case Reports in Oncology. 13: 508-514. PMID 32518546 DOI: 10.1159/000507281 |
0.295 |
|
| 2020 |
Gusdon AM, Cho SM, Mayasi Y, Malani R, Püttgen HA, Duffield A, Bolaños-Meade J, Lim M. Chronic Lymphocytic Leukemia Resulting in Hemorrhagic Brain Masses After Sepsis. The Neurohospitalist. 10: 64-68. PMID 31839869 DOI: 10.1177/1941874419859758 |
0.294 |
|
| 2017 |
Duffield AS, Ascierto ML, Anders RA, Taube JM, Meeker AK, Chen S, McMiller TL, Phillips NA, Xu H, Ogurtsova A, Berger AE, Pardoll DM, Topalian SL, Ambinder RF. Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy. Blood Advances. 1: 1324-1334. PMID 29296775 DOI: 10.1182/Bloodadvances.2017007260 |
0.289 |
|
| 2013 |
Samols MA, Smith NE, Gerber JM, Vuica-Ross M, Gocke CD, Burns KH, Borowitz MJ, Cornish TC, Duffield AS. Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas. American Journal of Clinical Pathology. 140: 579-87. PMID 24045557 DOI: 10.1309/Ajcptma1F6Lwytqv |
0.282 |
|
| 2018 |
Cottrell TR, Stein JE, Chaft JE, Thompson ED, Rekhtman N, Anagnostou V, Smith KN, Duffield AS, Anders RA, Isbell JM, Jones DR, Cuda JD, Battafarano R, Yang SC, Illei PB, et al. Abstract LB-154: Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small cell lung carcinoma (NSCLC): A proposal for quantitative immune-related pathologic response criteria (irPRC) Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-154 |
0.28 |
|
| 2015 |
Zeidan AM, Zeidner JF, Duffield A, Knaus HA, Ferguson A, Sheldon K, DeZern AE, Gojo I, Gore SD, Streicher H, Luznik L, Smith BD. Stabilization of Myelodysplastic Syndromes (MDS) Following Hypomethylating Agent (HMAs) Failure Using the Immune Checkpoint Inhibitor Ipilimumab: A Phase I Trial Blood. 126: 1666-1666. DOI: 10.1182/Blood.V126.23.1666.1666 |
0.278 |
|
| 2014 |
Rodić N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih IeM, Duffield AS, Montgomery EA, Gabrielson E, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American Journal of Pathology. 184: 1280-6. PMID 24607009 DOI: 10.1016/J.Ajpath.2014.01.007 |
0.275 |
|
| 2017 |
Wu M, Li L, Nguyen B, Small D, Duffield AS. DOCK2 Knockdown Mitigates Disease Progression in Murine Models Harboring a FLT3/ITD Mutation Blood. 130: 1216-1216. DOI: 10.1182/Blood.V130.Suppl_1.1216.1216 |
0.274 |
|
| 2015 |
Bynum JP, Duffield A, Ali SZ. Impact of flow cytometry in liver cytopathology. Acta Cytologica. 59: 51-60. PMID 25677814 DOI: 10.1159/000370042 |
0.272 |
|
| 2018 |
Ware AD, Birkness J, Duffield AS, Gocke CD. Molecular evidence of JAK2 p.V617F mutated pure erythroid leukemia arising from polycythemia vera. Virchows Archiv : An International Journal of Pathology. PMID 29611054 DOI: 10.1007/S00428-018-2347-8 |
0.27 |
|
| 2019 |
Miller KP, Venkataraman G, Gocke CD, Batista DA, Borowitz MJ, Burns KH, Pratz K, Duffield AS. Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide. American Journal of Clinical Pathology. PMID 31305869 DOI: 10.1093/Ajcp/Aqz087 |
0.264 |
|
| 2013 |
Tilson MP, Jones RJ, Sexauer A, Griffin CA, Morsberger LA, Batista DA, Small D, Burns KH, Gocke CD, Vuica-Ross M, Borowitz MJ, Duffield AS. Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1254-9. PMID 23769818 DOI: 10.1016/J.Bbmt.2013.05.022 |
0.259 |
|
| 2018 |
Cottrell TR, Thompson ED, Forde PM, Stein JE, Duffield AS, Anagnostou V, Rekhtman N, Anders RA, Cuda JD, Illei PB, Gabrielson E, Askin FB, Niknafs N, Smith KN, Velez MJ, et al. Pathologic Features of Response to Neoadjuvant Anti-PD-1 in Resected Non-Small Cell Lung Carcinoma: A Proposal for Quantitative Immune-Related Pathologic Response Criteria (irPRC). Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29982279 DOI: 10.1093/Annonc/Mdy218 |
0.259 |
|
| 2015 |
Chepovetsky J, Duffield AS, Pu JJ. Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphoma. Annals of Hematology. PMID 26542148 DOI: 10.1007/S00277-015-2542-5 |
0.258 |
|
| 2017 |
Zeidan AM, Knaus H, Robinson TM, Zeidner JF, Blackford AL, Rizzieri D, Frattini MG, Levy MY, Schroeder MA, Ferguson AK, Sheldon K, Dezern AE, Gojo I, Gore S, Streicher H, ... ... Duffield A, et al. A phase I trial of ipilimumab (ipi) in patients (pts) with myelodysplastic syndromes (MDS) after hypomethylating agent (HMAs) failure. Journal of Clinical Oncology. 35: 7010-7010. DOI: 10.1200/Jco.2017.35.15_Suppl.7010 |
0.255 |
|
| 2020 |
Wake LM, VandenBussche CJ, Ali SZ, Wagner-Johnston ND, Burns KH, Gocke CD, Vuica-Ross M, Borowitz MJ, Duffield AS. Flow cytometric analysis of fine needle aspirates is affected by tumor subtype, but not by anatomic location nor technique. Diagnostic Cytopathology. PMID 32212260 DOI: 10.1002/Dc.24417 |
0.24 |
|
| 2016 |
Bynum JP, Duffield A, Ali SZ. Importance of Flow Cytometry in the Cytopathologic Evaluation of Lymphoid Lesions Involving the Kidney. Acta Cytologica. PMID 27225856 DOI: 10.1159/000446269 |
0.24 |
|
| 2016 |
Ji J, Quintero-Rivera F, Xian R, Crane G, Baden K, Moschiano E, Karunasiri DK, Duffield AS, Rao N, Pullarkat S, Schreck R, Pillai R. Genomic Profiling of Plasmablastic Lymphoma Reveals Recurrent Copy Number Alterations and MYC Rearrangement as Common Genetic Abnormalities Cancer Genetics and Cytogenetics. 209: 290. DOI: 10.1016/J.Cancergen.2016.04.021 |
0.236 |
|
| 2018 |
Zeidan AM, Knaus HA, Robinson TM, Towlerton AM, Warren EH, Zeidner JF, Blackford AL, Duffield AS, Rizzieri D, Frattini MG, Levy YM, Schroeder MA, Ferguson A, Sheldon KE, DeZern AE, et al. A multi-center Phase 1 trial of ipilimumab in myelodysplastic syndrome patients following hypomethylating agent failure. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29716921 DOI: 10.1158/1078-0432.Ccr-17-3763 |
0.236 |
|
| 2019 |
Moliterno AR, Williams DM, Li L, Xian L, Luo L, Duffield AS, Rogers O, Spivak JL, Resar L. The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine Models Blood. 134: 472-472. DOI: 10.1182/Blood-2019-131432 |
0.224 |
|
| 2017 |
Wu M, Small D, Duffield AS. DOCK2: A novel FLT3/ITD leukemia drug target. Oncotarget. 8: 88253-88254. PMID 29179430 DOI: 10.18632/Oncotarget.21390 |
0.222 |
|
| 2018 |
Duffield AS, Borowitz MJ. Syphilitic lymphadenitis with abscess formation involving cervical lymph nodes. Blood. 131: 707. PMID 29438971 DOI: 10.1182/Blood-2017-11-817247 |
0.217 |
|
| 2014 |
Monroe AK, Burkholder BM, Butler NJ, Duffield AS. Sclerouveitis associated with Rosai-Dorfman disease in an HIV-infected patient. Ocular Immunology and Inflammation. 22: 236-8. PMID 24564426 DOI: 10.3109/09273948.2013.767914 |
0.214 |
|
| 2008 |
Duffield AS, Jarrar P, Shum C, Ahuja N, Yeo CJ, Sokoll LJ. Retroperitoneal masses with associated human chorionic gonadotropin production: Report of two cases. Clinica Chimica Acta; International Journal of Clinical Chemistry. 395: 166-9. PMID 18505680 DOI: 10.1016/J.Cca.2008.04.030 |
0.212 |
|
| 2013 |
Bailey EJ, Duffield AS, Greenblatt SM, Aplan PD, Small D. Effect of FLT3 ligand on survival and disease phenotype in murine models harboring a FLT3 internal tandem duplication mutation. Comparative Medicine. 63: 218-26. PMID 23759524 |
0.21 |
|
| 2019 |
Ware AD, Wake L, Brown P, Webster JA, Smith BD, Duffield AS. B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the Literature. Ajsp: Reviews & Reports. 24: 191-195. PMID 32656356 |
0.208 |
|
| 2009 |
Duffield AS, Lee TK, Miyamoto H, Carter HB, Epstein JI. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. The Journal of Urology. 182: 2274-8. PMID 19758635 DOI: 10.1016/J.Juro.2009.07.024 |
0.207 |
|
| 2021 |
Zhu R, Li L, Nguyen B, Seo J, Wu M, Seale T, Levis M, Duffield A, Hu Y, Small D. FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation. Signal Transduction and Targeted Therapy. 6: 186. PMID 34024909 DOI: 10.1038/s41392-021-00578-4 |
0.207 |
|
| 2010 |
Shouval R, Duffield AS, Gocke C, Lee LA, Brodsky RA. Pentostatin-induced hypereosinophilia with eosinophilic gastroenteritis. Leukemia & Lymphoma. 51: 1567-1569. PMID 20496999 DOI: 10.3109/10428194.2010.486879 |
0.206 |
|
| 2023 |
Xiao W, Amador C, Cook JR, Czader M, Dave S, Dogan A, Duffield A, Goodlad J, Nejati R, Ott G, Wasik M. B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. PMID 37040587 DOI: 10.1093/ajcp/aqad022 |
0.2 |
|
| 2009 |
Duffield AS, Epstein JI. Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides. The American Journal of Surgical Pathology. 33: 120-5. PMID 18971774 DOI: 10.1097/Pas.0B013E318185723E |
0.199 |
|
| 2021 |
Duffield AS, Webster J, Smith BD, Necciai JS, McCuiston A, Ware AD. Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad Mass. Head and Neck Pathology. PMID 33616851 DOI: 10.1007/s12105-021-01305-9 |
0.197 |
|
| 2023 |
Nejati R, Amador C, Czader M, Thacker E, Thakkar D, Dave SS, Dogan A, Duffield A, Goodlad JR, Ott G, Wasik MA, Xiao W, Cook JR. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. PMID 37085150 DOI: 10.1093/ajcp/aqad023 |
0.196 |
|
| 2023 |
Czader M, Amador C, Cook JR, Thakkar D, Parker C, Dave SS, Dogan A, Duffield AS, Nejati R, Ott G, Xiao W, Wasik M, Goodlad JR. Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. PMID 37052539 DOI: 10.1093/ajcp/aqad027 |
0.191 |
|
| 2020 |
Ambinder AJ, Norsworthy K, Hernandez D, Palau L, Paun B, Duffield A, Chandraratna R, Sanders M, Varadhan R, Jones RJ, Douglas Smith B, Ghiaur G. A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AML. Frontiers in Oncology. 10: 587062. PMID 33194741 DOI: 10.3389/fonc.2020.587062 |
0.183 |
|
| 2021 |
Robinett DM, Hummers LK, Morris M, Duffield AS, Shah AA. Primary CNS lymphoma in scleroderma: a case series. Journal of Scleroderma and Related Disorders. 6: 214-219. PMID 34350365 DOI: 10.1177/2397198320970395 |
0.178 |
|
| 2021 |
Young DJ, Nguyen B, Zhu R, Seo J, Li L, Levis MJ, Pratz KW, Duffield AS, Small D. Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis. Blood Advances. 5: 2285-2293. PMID 33914060 DOI: 10.1182/bloodadvances.2020002876 |
0.175 |
|
| 2020 |
Sidhom J, Siddarthan IJ, Lai B, Luo A, Hambley B, Bynum J, Duffield AS, Streiff MB, Moliterno AR, Imus PH, Gocke CB, Gondek LP, DeZern AE, Baras AS, Kickler TS, et al. Deep Learning for Distinguishing Morphological Features of Acute Promyelocytic Leukemia Blood. 136: 10-12. DOI: 10.1182/blood-2020-135836 |
0.16 |
|
| 2023 |
Amador C, Cook JR, Czader M, Duffield A, Goodlad J, Nejati R, Ott G, Xiao W, Dave S, Wasik MA, Dogan A. Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. PMID 37167533 DOI: 10.1093/ajcp/aqad045 |
0.152 |
|
| 2022 |
Duffield AS, Mullighan CG, Borowitz MJ. International Consensus Classification of acute lymphoblastic leukemia/lymphoma. Virchows Archiv : An International Journal of Pathology. 482: 11-26. PMID 36422706 DOI: 10.1007/s00428-022-03448-8 |
0.143 |
|
| 2023 |
Duffield AS, Dogan A, Amador C, Cook JR, Czader M, Goodlad JR, Nejati R, Xiao W, Happ L, Parker C, Thacker E, Thakkar D, Dave SS, Wasik MA, Ott G. Progression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. PMID 37167543 DOI: 10.1093/ajcp/aqad042 |
0.134 |
|
| 2023 |
Cook JR, Amador C, Czader M, Duffield A, Goodlad J, Ott G, Xiao W, Dave S, Thakkar D, Thacker E, Dogan A, Wasik M, Nejati R. Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. PMID 37186259 DOI: 10.1093/ajcp/aqad034 |
0.125 |
|
| 2021 |
Sidhom JW, Siddarthan IJ, Lai BS, Luo A, Hambley BC, Bynum J, Duffield AS, Streiff MB, Moliterno AR, Imus P, Gocke CB, Gondek LP, DeZern AE, Baras AS, Kickler T, et al. Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features. Npj Precision Oncology. 5: 38. PMID 33990660 DOI: 10.1038/s41698-021-00179-y |
0.117 |
|
| 2022 |
Rooper LM, White MJ, Duffield AS, Gagan J, London NR, Montgomery EA, Bishop JA. Limited sinonasal Rosai-Dorfman disease presenting as chronic sinusitis. Histopathology. PMID 35426462 DOI: 10.1111/his.14664 |
0.101 |
|
| 2023 |
Goodlad JR, Xiao W, Amador C, Cook JR, Happ L, Thakkar D, Dave S, Dogan A, Duffield A, Nejati R, Ott G, Wasik M, Czader M. Phenotypic and genotypic infidelity in B-lineage neoplasms, including transdifferentiation following targeted therapy: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. PMID 37085149 DOI: 10.1093/ajcp/aqad035 |
0.099 |
|
| 2023 |
Duffield A. Assessment and management of upper limb lymphoedema in advanced disease: a case study. British Journal of Community Nursing. 28: S22-S28. PMID 37757820 DOI: 10.12968/bjcn.2023.28.Sup10.S22 |
0.089 |
|
| 2009 |
Schneider AM, Duffield AS, Symer DE, Burns KH. Roles of retrotransposons in benign and malignant hematologic disease. Cellscience. 6: 121-145. PMID 20200603 |
0.083 |
|
| 2024 |
Barley K, Parekh A, Salam SP, Mendu DR, Shukla RP, Vatti D, Verina D, Stauffer C, Salib C, El Jamal S, Teruya-Feldstein J, Duffield AS, Leshchenko VV, Jagannath S, Balwani M, et al. Regression of Smoldering Myeloma with treatment of Gaucher disease. Blood Advances. PMID 38285963 DOI: 10.1182/bloodadvances.2023012304 |
0.076 |
|
| 2019 |
Moeenuddin Z, Kim-Kupfer C, Owchar E, Baker J, Duffield A, Santoro T. The Influence of Care Coordination on Patients With Special Health Care Needs in a Pediatric Residency Continuity Clinic. Global Pediatric Health. 6: 2333794X19848677. PMID 31106252 DOI: 10.1177/2333794X19848677 |
0.043 |
|
| 2011 |
Riedel S, Dionne K, Ellis C, Duffield A, Carroll KC, Parrish NM. Mycobacterium szulgai: an unusual cause of disseminated mycobacterial infections. Infection. 40: 463-8. PMID 22038111 DOI: 10.1007/s15010-011-0213-6 |
0.025 |
|
| Hide low-probability matches. |